Latest Updates
-
Swadesh, Chikankari, And A Year Of Handwork: Decoding Nita Ambani's Most Talked-About Sari -
Last Bada Mangal 2026: Significance, Rituals And Remedies For The Aakhri Budhwa Mangal -
From CRED to WhatsApp: How Kunal Shah Became The First Indian To Run A Global Tech Giant -
Mahesh Navami 2026: Significance, Origin Story, Tithi Timings, Puja Vidhi Of The Maheshwari Community Festival -
Oats Chilla Recipe: Your Healthy Protein Breakfast Solution -
International Olympic Day 2026: Date, Theme, History, And Everything You Should Know -
Horoscope for Today June 23, 2026 - Clear Focus & Steady Progress -
Samantha Ruth Prabhu Expecting Her First Child? Viral Video From Latest Appearance Fuels Buzz -
We Asked AI What You Should Never Ask It. Here Is What It Said -
Halwai Style Sweet Milk Cake Recipe: A Taste of Tradition
Sugary Diet May Up Risk Of Cancer: Study
Love to eat a sugar rich diet? Beware, it may fuel various forms of cancer by giving them the much needed energy to multiply, researchers say.
Love to eat a sugar rich diet? Beware, it may fuel various forms of cancer by giving them the much needed energy to multiply, researchers say.
The researchers found that one type of cancer called as squamous cell carcinoma (SqCC) -- found in lung, head and neck, esophageal and cervical -- is heavily dependent on sugar.

"It has been suspected that many cancer cells are heavily dependent on sugar as their energy supply, but it turns out that one specific type -- squamous cell carcinoma -- is remarkably more dependent," said Jung-whan Kim, assistant professor at the University of Texas.
Further, SqCC was also found to have highly active levels of a protein called glucose transporter 1, or GLUT1, responsible for transporting glucose into cells where the sugar provides a fundamental energy source and fuels cell metabolism.
"As a culture, we are very addicted to sugar. Excessive sugar consumption is not only a problem that can lead to complications like diabetes, but also, the evidence is mounting that some cancers are also highly dependent on sugar," Kim rued.

For the study, published in the journal Nature Communications, the team investigated differences in metabolism between two major subtypes of non-small cell lung cancer -- adenocarcinoma (ADC) and SqCC.
The researchers investigated the effect of a GLUT1 inhibitor in human lung tissue, isolated lung cancer cells and mice with both types of non-small cell lung cancer.
When GLUT1 inhibitors was given to mice with lung cancer, the squamous cancer diminished, but not the adenocarcinoma.
"There was not a complete eradication, but tumour growth slowed," Kim said.
"Overall, our findings indicate that GLUT1 could be a potential target for new lines of drug therapy, especially for SqCC," he suggested.
With Inputs From IANS
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications